Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Clin Infect Dis. 2023 Feb 8;76(3):e1244-e1251. doi: 10.1093/cid/ciac483.
A recent study from Taiwan suggested that Clostridium innocuum may be an unrecognized cause of antibiotic-associated diarrhea (AAD) and clinically indistinguishable from Clostridioides difficile infection. Our objective was to compare C. innocuum prevalence and strain between those with AAD and asymptomatic controls.
In this cross-sectional study, we collected stool from 200 individuals with AAD and 100 asymptomatic controls. We evaluated the association between AAD and C. innocuum in stool using anaerobic culture and quantitative polymerase chain reaction (qPCR). To identify strain-specific associations with AAD, we performed whole-genome sequencing of C. innocuum isolates using Illumina MiSeq and constructed comparative genomics analyses.
C. innocuum was isolated from stool of 126/300 (42%) subjects and more frequently from asymptomatic controls than AAD subjects (50/100 [50%] vs 76/200 [38%], respectively; P = .047). C. innocuum isolation frequency was not associated with AAD in either the adult or pediatric subgroups. C. innocuum and C. difficile were frequently co-prevalent in individuals with and without diarrhea. There were no phylogenetic differences or accessory genome associations between C. innocuum isolates from AAD subjects and asymptomatic controls.
C. innocuum was frequently isolated and at a greater frequency in asymptomatic controls than those with AAD. We did not identify strain lineages or accessory genomic elements associated with AAD. These data highlight that differentiating C. innocuum-associated diarrhea from asymptomatic colonization, and differentiating diarrhea caused by C. difficile from C. innocuum, are clinical microbiology challenges that require additional investigation to identify host-specific factors and/or biomarkers that distinguish these conditions.
最近来自中国台湾的一项研究表明, innocuum 可能是抗生素相关性腹泻(AAD)的一个未被识别的原因,并且在临床上与艰难梭菌感染无法区分。我们的目的是比较 AAD 患者和无症状对照者中 innocuum 的患病率和菌株。
在这项横断面研究中,我们收集了 200 例 AAD 患者和 100 例无症状对照者的粪便。我们使用厌氧培养和定量聚合酶链反应(qPCR)评估了 AAD 与 innocuum 之间的关联。为了确定与 AAD 相关的菌株特异性关联,我们使用 Illumina MiSeq 对 innocuum 分离株进行了全基因组测序,并构建了比较基因组学分析。
126/300(42%)的患者粪便中分离出 innocuum,无症状对照者中分离出 innocuum 的频率高于 AAD 患者(50/100[50%]与 76/200[38%],分别;P=.047)。在成人和儿科亚组中, innocuum 分离频率与 AAD 均无相关性。无论有无腹泻, innocuum 和艰难梭菌均常同时存在。AAD 患者和无症状对照者的 innocuum 分离株之间没有系统发育差异或辅助基因组关联。
innocuum 常被分离出来,且在无症状对照者中的分离频率高于 AAD 患者。我们未发现与 AAD 相关的菌株谱系或辅助基因组元件。这些数据表明,区分 innocuum 相关性腹泻与无症状定植,以及区分艰难梭菌引起的腹泻与 innocuum 引起的腹泻,是临床微生物学面临的挑战,需要进一步研究以确定区分这些情况的宿主特异性因素和/或生物标志物。